As a Republican-controlled House of Representatives with a small majority opens for business in January, one member has especially big ideas for saving patients money on prescription drug costs -- and the research to back it up.A year ago, Rep. James Comer (RKY) released a comprehensive report on the role of pharmacy benefit managers in the nation's healthcare system. The result does not make for pleasant reading. It is largely a tale of how greedy middlemen have taken advantage of existing legal loopholes and lax oversight to create an industry that raked in $28 billion in profits in 2019 -- ...